Advances in Drug Development & Delivery: Challenges, Patient-Centricity, and Innovative Technologies

Tuesday, June 12, 2018 from 11:00 AM to 4:00 PM (CDT)

JLABS @ TMC Houston, TX

register now button


Making the right choices is important in today’s R&D environment, especially considering the various pressures on developers such as time, resources, and funding. Short term thinking can lead to long term problems leading to missed timelines, escalating costs, and even regulatory issues in later phases. These factors can unfortunately contribute to non-optimal drug products unless they are addressed upfront and incorporate patient focused design principles to promote better drug performance and patient outcomes.

This event will focus on key considerations for developing the best biologics therapeutics:

  • Avoiding the biggest pitfalls in drug development
  • Incorporating patient considerations in designing a drug product
  • Latest trends and technologies for biologics therapeutics

register now button


11:00 AM | Registration, Lunch and Networking

12:00 PM | Biotech: Birth to Solid Food

               -Mr. Andrew L. Strong | Partner, Pillsbury Winthrop Shaw Pitman LLP

12:45 PM | Efficient Expression of Complex Proteins in Mammalian Cells

               -Dr. Greg Bleck | Global Head R&D, Biologics, Catalent Biologics

1:30 PM | Orbit: An MD Anderson Translational Engine for the Discovery and Development of Therapeutics Antibodies

               -Dr. DongXing Zha | Associate Director, ORBIT, MD Anderson Cancer Center

2:15 PM | Break

2:30 PM | Importance of Formulation Development During Drug Substance Process Development

               -Dr. Yunsong (Frank) Li | Director, Process Development, Catalent Biologics

3:15 PM | Beyond “Drugs”

               -Dr. Mauro Ferrari | Ernest Cockrell Jr. Presidential Distinguished Chair, President & CEO, Houston Methodist Research Institute & Director, Institute for Academic Medicine

4:00 PM | Closing Remarks